Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity - Su, Tao; Huang, Chunhua; Yang, Chunfang; Jiang, Ting; Su, Junfang; Chen, Minting; Fatima, Sarwat; Gong, Ruihong; Hu, Xianjing; Bian, Zhaoxiang; Liu, Zhongqiu; Kwan, Hiu Yee (Pharmacological research, 2020)
Keywords: 3T3-L1 Cells; Adipose Tissue - drug effects; Animals; Anti-Obesity Agents - pharmacology; Anti-Obesity Agents - therapeutic use; Apigenin; Apigenin - pharmacology; Apigenin - therapeutic use; Body Weight - drug effects; CD36 Antigens - genetics; CD36 Antigens - metabolism; Cluster of differentiation 36; Diet, High-Fat; HEK293 Cells; High fat diet; Humans; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Dynamics Simulation; Obesity, Abdominal - drug therapy; Obesity, Abdominal - metabolism; Signal transducer and activator of transcription 3; STAT3 Transcription Factor - genetics; STAT3 Transcription Factor - metabolism; Visceral obesity; BAT; Apigenin; STAT3; SAT; Signal transducer and activator of transcription 3; VAT; EAT; Cluster of differentiation 36; Visceral obesity; High fat diet